Page 6 - Singular Genomics News Today

Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it weigh in compared to its peers? We will compare Singular Genomics Systems to similar companies based on the strength of its dividends, earnings, analyst recommendations, risk, profitability, institutional ownership and valuation. Earnings & […]

Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it contrast to its rivals? We will compare Singular Genomics Systems to related companies based on the strength of its valuation, analyst recommendations, institutional ownership, profitability, dividends, earnings and risk. Valuation & Earnings This […]

Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it weigh in compared to its peers? We will compare Singular Genomics Systems to similar companies based on the strength of its earnings, profitability, dividends, analyst recommendations, risk, institutional ownership and valuation. Profitability This […]

Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it weigh in compared to its peers? We will compare Singular Genomics Systems to related businesses based on the strength of its earnings, risk, profitability, institutional ownership, dividends, analyst recommendations and valuation. Earnings and […]

Our roundtable found three biotechs with a nice cash cushion.

You've heard the adage "buy the dip," but not all dips are made equal. There are several strategies for finding worthwhile discounted stocks.

Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it contrast to its rivals? We will compare Singular Genomics Systems to related companies based on the strength of its earnings, profitability, dividends, analyst recommendations, institutional ownership, risk and valuation. Insider and Institutional Ownership […]

Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it compare to its rivals? We will compare Singular Genomics Systems to related businesses based on the strength of its valuation, analyst recommendations, institutional ownership, earnings, profitability, dividends and risk. Analyst Ratings This is […]

OMIC earnings call for the period ending March 31, 2022.

San Diego–based Illumina, long the dominant player in NGS technology, faces intense competition from crosstown rivals Element Biosciences and Singular Genomics.